Background
It is believed that the process of malignant tumor is a multiple-step process caused by the accumulation of abnormal expression of oncogenes and tumor suppressor genes. Therefore, the identification of commonly amplified chromosomal region and corresponding overexpressed oncogenes within the region is imperative to understand the molecular mechanism of cancer development. Amplification of chromosomal region 3q26 is frequently detected in solid tumors, including ovarian [
1], lung [
2], esophageal [
3], prostate [
4], breast [
5], and nasopharyngeal cancers [
6], suggesting that 3q26 contains an oncogene(s) related to the pathogenesis of human cancers. Using hybrid selection approach, we identified a candidate oncogene, eukaryotic translation initiation factor 5A2 (
eIF5-A2), from 3q26.2 [
7,
8]. The functions of
eIF-5A2 are mainly revealed in cancer initiation and progression. The tumorigenic ability of
eIF5-A2 has been demonstrated by several
in vitro evidences:
eIF-5A2 stably transfected LO2 cells (immortalized human liver cell line) displayed increased colony formation in soft agar and xenograph formation in nude mice; reduction of eIF-5A2 in ovarian cancer cell line UACC-1598 inhibits cell growth; and the oncogenic ability of
eIF5-A2 can be blocked by
eIF-5A2 silencing [
7‐
9]. Previously, we showed that overexpression of eIF-5A2 at the protein level was significantly associated with the advanced stages of ovarian cancer [
8]. Similarly, Marchet
et al. recently reported that overexpression of eIF-5A2 is associated with a higher risk of lymph node metastasis in human gastric adenocarcinomas [
10]. Recently, Zender
et al. identified that
eIF-5A2 is amplified in human cancer using representational oligonucleotide microarray analysis (ROMA), and is required for proliferation of
XPO4-deficient tumor cells and promotes hepatocellular carcinoma in mice [
11]. However, the
in vivo function of
eIF-5A2 is still not clear.
To further investigate the functions of the
eIF-5A2 gene
per se, we generated
eIF-5A2 transgenic mice. Unexpectedly, the
eIF-5A2 transgenic mice exhibit accelerated organismal aging phenotypes instead of forming spontaneous tumors. Cancer is assumed to be a disease of accumulated aged cells because of the close link between incidence of the cancer and the aging process. For decades, age has been regarded as the largest risk factor associated with the cancer initiation, which is supported by cancer incidence rising exponentially with age [
12,
13]. Mechanistically, genomic instability in somatic cells has been implicated as one of the major stochastic causes of aging [
14‐
16]. Furthermore, cellular senescence, a potential
in vitro counterpart of organismal aging, was demonstrated by several recent studies as a barrier to tumorigenesis, and contributes to the cytotoxicity of certain anticancer agents [
17]. However, it is not clear whether aging functions the same way as cellular senescence to suppress tumor initiation
in vivo. Also, there is no direct evidence to elucidate the functional contribution of senescent cells towards the onset of aging.
In this study, we found that eIF-5A2 overexpression triggers premature aging in multiple organs of the transgenic mice. We further demonstrated that supraphysiological expression of eIF-5A2 repressed p19 expression and therefore impaired p53 levels. This allowed for the accumulation of chromosomal instability, which ultimately led to organismal aging. To our knowledge, this study revealed for the first time a role of putative oncogenic eIF-5A2 in accelerating the aging process. Moreover, the accelerated aging process shows tumor suppression effects in vivo, and cellular senescence is not required for this single genetic change caused aging.
Methods
Generation of eIF-5A2transgenic mice
A 462 bp human eIF-5A2 cDNA fragment was cloned into the pCAGGS vector. The linearized constructs were injected into one-cell-stage F1 mouse embryos, which were transplanted into pseudo-pregnant females. All resulting pups were screened for the presence of the transgene using a pair of primers from the vector sequence and a pair of primers from the human eIF-5A2 gene. For studies relying on timed pregnancies, mating pairs were established and mice were monitored daily for vaginal plugs, the presence of which would indicate 0.5 days post-copulation. Animal experimentation was done in accordance with the guidelines of the University of Hong Kong regarding the care and use of laboratory animals.
Western and Northern blot analysis
For Western blot analysis, Protein lysates were prepared with RIPA buffer (1 × PBS, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail). About 10 μg of lysate was separated by SDS-polyacrylamide gel electrophoresis, transferred to a PVDF Hybond-P membrane (Amersham Pharmacia Biotechnology, Piscataway, NJ), and detected by antibodies for eIF-5A2 (a mouse monoclonal antibody raised against the 54 residues of eIF-5A2), p53 (Zymed, San Francisco, CA), p21 (Upstate, Temecula, CA), p19 (Upstate, Lake Placid, NY), CDK4 (Cell Signaling Technology, Beverley, MA), and γ-tubulin (Sigma, St. Louis, MO). For Northern blot analysis, total cellular RNA was prepared using the TRIzol/chloroform method. Twenty microgram of RNA was size fractionated, transferred to a nylon membrane, and hybridized with a
32P-labeled human
eIF-5A2 specific probe as described previously[
7,
8].
Histological analysis, immunohistochemistry, senescence and BrdU incorporation assay
Fresh mouse tissues were fixed in 4% cold paraformaldehyde in PBS, processed into serial paraffin sections, and stained with Mayer's hematoxylin-eosin staining. Immunohistochemistry (IHC) was performed using the following antibodies: eIF-5A2 (1:500 dilution), PCNA (1:500 dilution, Santa Cruz Biotechnology, Santa Cruz, CA). Internal standardization was achieved by comparing only images stained with the same antibodies in the same experiment, captured with identical parameters, and scaled and displayed identically. For β-galactosidase staining, MEF cells were stained for senescence-associated acidic β-galactosidase activity according to the manufacturer's protocol (Cell Signaling Technology, Beverley, MA). BrdU (100 mg/g of body weight) was injected i.p. into pregnant females. Then the animals were killed 2 h after injection and the mouse tissues or embryos were fixed in 4% paraformaldehyde at 4°C overnight. Then the sections were processed for stained with BrdU staining kit (ZYMED) according to the manufacturer's protocol.
Wound healing experiments
4-month old mice were anaesthetized with methoxyfluorane, and the dorsum was shaved and cleaned with alcohol. Three equidistant 1-cm full-thickness incisional wounds were made through the skin and panniculus carnosus muscle. Wounds were measured at days 1, 2, 3 and 4 post-wounding, and wounded skin specimens were collected and bisected for histology at day 4 post-wounding.
Bone X-ray imaging and calcification analysis
Individual mice were subjected to an X-ray imager for the detection of kyphosis and osteoporosis. In brief, mice were anaesthetized with 2% isofluorane and images were taken by a 600P X-ray mammogram machine (General Electric Co., Albuquerque, NM) with a dose of 15 kV for 100 sec. For calcification analysis, embryos were eviscerated and the skin was removed. The embryos were fixed in 95% ethanol and stained in Alcian blue solution and Alizarin red solution overnight as described previously[
18].
Isolation of mouse embryo fibroblast (MEF) cells
E13.5 embryos were digested at 37°C for 10 min in 0.2% trypsin (Sigma, St. Louis, MO) in PBS (pH 7.4). The cell suspension was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS at 37°C. For cell proliferation analysis, 5 × 104 wild-type and eIF-5A2 transgenic MEF cells were plated on 6-well plates and cell numbers were counted every day for up to 6 days. For flowcytometry test, cells were fixed in 70% ethanol, stained with propidium iodide, and analyzed by flow cytometer.
Cytogenetic analysis, FISH and SKY
Metaphase spreads were prepared from either cultured MEF cells or bone marrow lymphocytes. Metaphases were harvested from cultured MEFs by Colcemid treatment (0.03 μg/ml) for 3 hr or from bone marrow lymphocytes in tested mice by colchincine treatment (3 mg/kg, intraperitoneal injection). Metaphase spreads were stained by standard trypsin-Giemsa banding method and analyzed under microscope as described previously [
7].
For fluorescence
in situ hybridization (FISH) analysis, the whole transgene construct was used as a probe, which was labeled with Spectrum Red-dUTP by nick translation (Life Technologies, Inc.). The labeled probe was then hybridized to prebanded wild-type or
eIF-5A2 transgenic MEF metaphase chromosomes as described previously [
7].
Spectral karyotyping (SKY) was performed using a SKY probe (Applied Spectral Imaging, Migdal Ha'Emek, Israel) as described previously [
19,
20]. The signal detection followed the recommendations of the SKY probe manufacturer. SKY image capturing and karyotyping were performed using the SkyVision Imaging System equipped with a Zeiss Axioplan 2 fluorescence microscope.
Telomerase activity assay
The telomere repeat amplification protocol (TRAP) assay was performed using the TRAPEZE kit (Invitrogen, New York, NY) following the manufacturer's protocol. Except for negative control (lysis buffer), 0.05 μg protein was used for each PCR, which was run for 33 cycles.
Statistical analysis
Statistical analysis was performed using the SPSS software (SPSS Standard version 8.0). Significance of difference was analyzed using Student's t tests. A significant difference was considered when the p value was less than 0.05.
Discussion
Our studies have identified eIF-5A2 as a single genetic change involved in accelerating the aging process in mice. Overexpression of eIF-5A2 results in aging phenotypes in multiple organs in vivo, but is insufficient for triggering cellular senescence. We provide here the mammalian genetic evidence for the notion that organismal aging is not always linked to cellular senescence.
A key finding in our study is that activation of oncogene eIF-5A2 represses p19 levels and impairs its stabilization of p53. Consequently, p53 transcriptionally down-regulates p21Cip1 and therefore increases CDK4 in response to p19 inhibition. However, these eIF-5A2 mediated pathway alterations function very differentially in in vivo and in vitro contexts. In vivo, down-regulated p19, p53 and p21 and up-regulated CDK4 promote cell proliferation and increase telomere activity, which belong to oncogenic transformation category. Consequently, we observed partial transformation of eIF-5A2 MEFs, but not oncogene activation induced cellular senescence. In the mouse, the activation of eIF-5A2 and subsequent alteration of the p19-p53-p21 pathway, leads to accelerated aging phenotypes. This confirms again the fate of oncogene activation is context dependent. The activation of eIF-5A2 alone in an in vitro system shows a mild transformation capability and is insufficient to trigger the senescence response. While in the intact mice context, the stress of eIF-5A2 activation causes whole body responses and navigates to accelerated aging to suppress tumorigenesis in vivo. As a result, there is no spontaneous tumor formation in eIF-5A2 mice, and they are not cancer-prone, and they do not respond to cancer reagents.
Notably, the p19 mediated impairment of p53, allowing the accumulation of numerical genomic instability, was revealed in both MEFs and mice. Human and mouse models of accelerated aging frequently involve alterations in genome maintenance mechanisms [
21]. p53 plays a critical role in cell cycle regulation and the maintenance of genetic stability, which is associated with its function in DNA damage reparation. Genomic instability has been implicated as a major causal factor in early onset of the aging phenotype, which was observed in mtr-/- mice and Ku80 null mice [
27,
28]. Therefore, we hypothesized that the molecular mechanism of
eIF-5A2 in aging is associated with p53-dependent chromosomal instability. The data we collected from both
in vivo and
in vitro studies showed a variety of chromosomal instability, including higher incidences of unaligned and/or misaligned chromosomal materials, anaphase bridges, and micronuclei. They contribute to differential fates of either aging or transformation depending on the different contexts, confirming the curial role of genomic instability in both tumorigenesis and aging.
eIF-5A2 was originally identified as a proto-oncogene whose overexpression leads to cancerous transformation of hepatocellular carcinoma cell lines, and contributes to cancer progression and metastasis. However, no spontaneous tumors were detected in transgenic mice overexpressing eIF-5A2. One possible explanation could be the life span of the eIF-5A2 transgenic mouse is too short to allow for the accumulation of extra genetic changes, and defeat aging phenotypes, to form a detectable tumor. In conclusion, we found that activation of eIF-5A2 causes p53-mediated genomic instability and accelerates the aging phenotype in multiple tissues in mice. This finding provides more insight into the mechanism of accelerated aging caused by oncogene activation in vivo.
Our study also revealed that cellular senescence is not required for the organismal aging process. Cellular senescence was considered as a potential counterpart of organismal aging under certain circumstances [
29‐
31]. Senescent cells have typical physiological changes, including large and flat morphology, higher acidic β-galactosidase enzymatic activity and profound growth defects. The growth arrest of cellular senescence is actually a tumor suppressor mechanism to resist tumorigenesis via shortening the longevity of cells and preventing cell proliferation. In addition, senescences often down-regulate extracellular matrix production and upregulate inflammatory cytokines to modulate the microenviroment or immune response [
13]. Although we observed striking aging phenotypes in
eIF-5A2 mice, there is no evidence that the aging effect of
eIF-5A2 is associated with cellular senescence. Our model demonstrates that cellular senescence is not required for the initiation of
eIF-5A2 mediated organismal aging. In another words, organismal aging is not necessarily the consequence of the accumulated senescent cells. This type of separation of cellular senescence and organism aging can be cell type and context dependent.
Conclusions
In the past several decades, age has been regarded as the largest risk factor tightly linked to the initiation of cancer. Cellular senescence, a potential in vitro counterpart of organismal aging, contributes to the cytotoxicity of certain anticancer agents. Here, we reveal for the first time a role of putative oncogenic eIF-5A2 in accelerating the aging process by increasing chromosome instability, and cellular senescence is not required for the aging phenotypes in eIF-5A2 mice. Thus, we conclude that organismal aging is not necessarily the consequence of the accumulated senescent cells. This type of separation of cellular senescence and organism aging can be cell type and context dependent.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MH, JD and HK performed the majority of experiments. WD, LL and SY carried out the cytogenetic studies. SS participated in the generation of transgenic mice. SL, TZ and GX helped with bone X-ray imaging analysis. XY supervised this project and provided suggestions. MH, SS and XY drafted and revised the manuscript. All authors reviewed, critiqued and offered comments to the text and approved the final version of manuscript.